Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1423053 MIAMI, FL
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$30,415,566
+$30,047,889 QoQ
Shares Held
1,160,014
+7333.1% QoQ
Ownership
0.923%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#25
of 271 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Derivatives in ARQT

reported options exposure · as of Jun 30, 2026
CallValue
$2,480,412
CallShares
94,600
PutValue
$367,080
PutShares
14,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,739,871 across 435 Biotechnology names. ARQT ranks #41 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in ARQT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $30,415,566 1,160,014
2026-06-30 $2,480,412 94,600
2026-06-30 $367,080 14,000
2026-03-31 $367,677 15,606
2026-03-31 $1,340,564 56,900
2026-03-31 $605,492 25,700
2025-12-31 $984,456 33,900
2025-12-31 $3,252,480 112,000
2025-12-31 $4,505,788 155,158
2025-09-30 $510,835 27,100
2025-09-30 $1,232,790 65,400
2025-09-30 $3,341,501 177,268
2025-06-30 $594,448 42,400
2025-06-30 $2,039,811 145,493
2025-06-30 $1,167,866 83,300
2025-03-31 $4,849,572 310,075
2025-03-31 $1,546,796 98,900
2025-03-31 $478,584 30,600
2024-12-31 $399,791 28,700
2024-12-31 $1,242,109 89,168
2024-12-31 $841,372 60,400
2024-09-30 $28,188,978 3,031,073
2024-09-30 $834,210 89,700
2024-09-30 $305,040 32,800
2024-06-30 $193,440 20,800
2024-06-30 $27,273,617 2,932,647
2024-06-30 $746,790 80,300
2024-03-31 $842,350 85,000
2024-03-31 $1,348,751 136,100
2024-03-31 $18,970,415 1,914,270
2023-12-31 $170,221 52,700
2023-12-31 $31,977 9,900
2023-09-30 $60,534 11,400
2023-09-30 $1,330,340 250,535
2023-09-30 $130,626 24,600
2023-06-30 $193,459 20,300
2023-06-30 $365,952 38,400
2023-06-30 $518,507 54,408
2023-03-31 $2,986,731 271,521
2023-03-31 $96,800 8,800
2023-03-31 $194,700 17,700
2022-12-31 $142,568 9,633
2022-12-31 $134,680 9,100
2022-12-31 $187,960 12,700
2022-09-30 $1,538,641 80,515
2022-06-30 $381,449 17,900
2022-06-30 $4,102,409 192,511
2022-03-31 $3,403,241 176,700
2022-03-31 $687,582 35,700
2021-12-31 $302,804 14,600